3 Clinical Trial Setbacks: Ovid, Histogen and Minerva,

Three biotech companies reported disappointing news today on clinical trials. Here’s a look. Ovid Therapeutics’ Phase III NEPTUNE Trial., Three biotech companies reported disappointing news today on clinical trials. Here’s a look. Ovid Therapeutics’ Phase III NEPTUNE Trial., Read More

Scroll to Top